Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Fallopian Tube Neoplasms × Reverse Transcriptase Polymerase Chain Reaction × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Rectal Neoplasms 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Leukemia 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Multiple Myeloma 1 Liposarcoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1

Interventions

Paclitaxel 49 Carboplatin 47 Bevacizumab 35 Taxes 22 liposomal doxorubicin 18 Gemcitabine 16 pembrolizumab 14 Immunoglobulin G 14 Disulfides 14 Topotecan 10 Cisplatin 9 rucaparib 8 olaparib 7 Docetaxel 7 Cyclophosphamide 7 mirvetuximab soravtansine 6 cediranib 6 Magnetic Resonance Spectroscopy 6 Doxorubicin 6 pazopanib 5 Specimen Handling 5 Nivolumab 5 sargramostim 4 niraparib 4 Surgical Procedures, Operative 4 Cytoreduction Surgical Procedures 4 Albumin-Bound Paclitaxel 4 fludarabine phosphate 3 belinostat 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡